Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications

References

• Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004; 364: 1343–1360
   PubMed Web of Science ®Google Scholar
• Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 2003; 289: 1136–1142
   PubMed Web of Science ®Google Scholar
• Morris CR, Kuypers FA, Larkin S, Vichinsky EP, Styles LA. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 2000; 22: 515–520
   PubMed Web of Science ®Google Scholar
• Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO, III. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation 2003; 107: 271–278
   PubMed Web of Science ®Google Scholar
• Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, Lacombe C, Galacteros F, Adnot S. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 2001; 97: 1584–1589
   PubMed Web of Science ®Google Scholar
• Morris CR, Morris SMJ, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP. Arginine therapy: A new treatment for pulmonary hypertension in sickle cell disease?. Am J Respir Crit Care Med 2003; 168: 63–69
   PubMed Web of Science ®Google Scholar
• Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J, Jr, Shah AK, Mankad VN. Investigators of the cooperative study of sickle cell disease. Causes of death in sickle cell disease: An autopsy study. Br J Haematol 2003; 123: 359–365
   PubMed Web of Science ®Google Scholar
• Acar P, Maunoury C, de Montalembert M, Dulac Y. Abnormalities of myocardial perfusion in sickle cell disease in childhood: A study of myocardial scintigraphy. Arch Mal Coeur Vaiss 2003; 96: 507–510
   PubMedGoogle Scholar
• O’Rourke M. Mechanical principles in arterial disease. Hypertension 1995; 26: 2–9
   PubMed Web of Science ®Google Scholar
• Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236–1241
   PubMed Web of Science ®Google Scholar
• Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, Lacombe C, Galacteros F, Adnot S. Endothelial dysfunction in patient with sickle cell disease is related to selective impairment of shear stress-mediated vasodilatation. Blood 2001; 97: 1584–1589
   PubMed Web of Science ®Google Scholar
• Ataga KI, Key NS. Hypercoagulability in sickle cell disease: New approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007; 2007: 91–96
   Google Scholar
• Francis RB. Platelets, coagulation, and fibrinolysis in sickle cell disease: Their possible role in vascular occlusion. Blood Coagul Fibrinolysis 1991; 2: 341–353
   PubMed Web of Science ®Google Scholar
• Mohan JS, Lip GYH, Wright J, Bareford D, Blann AD. Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: Relationship to genotype and to inflammation. Blood Coagul Fibrinolysis 2005; 16: 209–214
   PubMed Web of Science ®Google Scholar
• Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: A curious paradox. Am J Med 2003; 115: 721–728
   PubMed Web of Science ®Google Scholar
• Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99: 36–43
   PubMed Web of Science ®Google Scholar
• Pattanapanyasat K, Gonwong S, Chaichompoo P, Noulsri E, Lerdwana S, Sukapirom K, Siritanaratkul N, Fucharoen S. Activated platelet-derived microparticles in thalassaemia. Br J Haematol 2007; 136: 462–471
   PubMed Web of Science ®Google Scholar
• van Beers EJ, Schaap MCL, Berkmans RJ, Nieuwland R, Sturk A, van Doormaal FF, Meijers JC, Biemond BJ, CURAMA study group. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009; 94: 1513–1519
   PubMed Web of Science ®Google Scholar
• Piccin A, Murphy WG, Smith OP. Circulating microparticles: Pathophysiology and clinical implications. Blood Rev 2007; 21: 157–171
   PubMed Web of Science ®Google Scholar
• Horstman LL, Ahn YS. Platelet microparticles: A wide-angle perspective. Crit Rev Oncol Hematol. 1999; 30(2)111–142
   PubMed Web of Science ®Google Scholar
• Owens AP, III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 1284–1297
   PubMed Web of Science ®Google Scholar
• Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: A potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48: 180–186
   PubMed Web of Science ®Google Scholar
• VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277–287
   PubMed Web of Science ®Google Scholar
• Freyssinet JM. Cellular microparticles: What are they bad or good for?. J Thromb Haemost 2003; 1: 1655–1662
   PubMed Web of Science ®Google Scholar
• Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439–451
   PubMed Web of Science ®Google Scholar
• Nieuwland R, Sturk A. Why do cells release vesicles?. Thromb Res 2010; 125(Suppl. I)S49–S51
   Google Scholar
• Holme PA, Solum NO, Brosstad F, Roger M, Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and Western blotting. Thromb Haemost 1994; 72: 666–671
   PubMed Web of Science ®Google Scholar
• Gawaz M, Neumann FJ, Ott I, Schiessler A, Schomig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 1996; 93: 229–237
   PubMed Web of Science ®Google Scholar
• Habib A, Kunzelmann C, Shamseddeen W. Elevated levels of circulating procoagulant microparticles in patients with β-thalassemia intermedia. Haematologica. 2008; 93(6)941–942
   PubMed Web of Science ®Google Scholar
• Ataga KI. Hypercoagulability and thrombotic complications in hemolytic anemias. Haematologica 2009; 94(11)1481–1484
   PubMed Web of Science ®Google Scholar
• Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678–2683
   PubMed Web of Science ®Google Scholar
• Chen Y, Davis-Gorman G, Watson RR, McDonagh PF. Platelet CD62p expression and microparticle in murine acquired immune deficiency syndrome and chronic ethanol consumption. Alcohol Alcohol 2003; 38: 25–30
   PubMed Web of Science ®Google Scholar
• Shigeta O, Kojima H, Jikuya T, Terada Y, Atsumi N, Sakakibara Y, Nagasawa T, Mitsui T. Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass. Circulation 1997; 96: 569–574
   PubMed Web of Science ®Google Scholar
• Horigome H, Hiramatsu Y, Shigeta O, Nagasawa T, Matsui A. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J Am Coll Cardiol 2002; 39: 1072–1077
   PubMed Web of Science ®Google Scholar
• Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002; 51: 2840–2845
   PubMed Web of Science ®Google Scholar
• Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002; 69(3)229–234
   PubMed Web of Science ®Google Scholar
• Wethers DL. Sickle cell disease in childhood: Part I. Laboratory diagnosis, pathophysiology and health maintenance. Am Fam Physician 2000; 62: 1013–1020
   PubMed Web of Science ®Google Scholar
• Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325: 11–16
   PubMed Web of Science ®Google Scholar
• Castro O, Gladwin MT. Pulmonary hypertension in sickle cell disease: Mechanisms, diagnosis, and management. Hematol Oncol Clin North Am 2005; 19: 881–896
   PubMed Web of Science ®Google Scholar
• Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998; 92: 3082–3089
   PubMed Web of Science ®Google Scholar
• Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Casella JF. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 2006; 118: 1916–1924
   PubMed Web of Science ®Google Scholar
• Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol 2002; 9: 123–126
   PubMed Web of Science ®Google Scholar
• Pattanapanyasat K, Noulsri E, Fucharoen S, Lerdwana S, Lamchiagdhase P, Siritanaratkul N, Webster HK. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom 2004; 57: 23–31
   PubMed Web of Science ®Google Scholar
• Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, Boulanger CM. Microparticles, vascular function, and atherothrombosis. Circ Res 2011; 109: 593–606
   PubMed Web of Science ®Google Scholar
• Smiley D, Dagogo-Jack S, Umpierrez G. Therapy insight: Metabolic and endocrine disorders in sickle cell disease. Nat Clin Pract Endocrinol Metab 2008; 4: 102–109
   PubMedGoogle Scholar
• Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841–843
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639–646
   PubMed Web of Science ®Google Scholar
• Yuana Y, Bertina RM, Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011; 105: 396–408
   PubMed Web of Science ®Google Scholar
• Schroit AJ, Madsen JW, Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 1985; 260: 5131–5138
   PubMed Web of Science ®Google Scholar
• Allan D, Limbrick AR, Thomas P, Westerman MP. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature 1982; 295: 612–613
   PubMedGoogle Scholar
• Adams GT, Snieder H, McKie VC, Clair B, Brambilla D, Adams RJ, Kutlar F, Kutlar A. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: Design of a case-control association study and genomewide screen. BMC Med Genet 2003; 4: 6
   PubMedGoogle Scholar
• Westerman MP, Cole ER, Wu K. The effect of spicules obtained from sickle red cells on clotting activity. Br J Haematol 1984; 56: 557–562
   PubMedGoogle Scholar
• Michaeli JM, Mittelman M, Grisaru D, Rachmilewitz EA. Thromboembolic complications in beta thalassemia major. Acta Haematol 1992; 87: 71–74
   PubMed Web of Science ®Google Scholar
• Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007; 66: 159–165
   PubMed Web of Science ®Google Scholar
• Vallar L, Regnault V, Latger-Cannard V, Lecompte T. Beta 2-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa. Thromb Haemost 2001; 85: 314–219
   PubMed Web of Science ®Google Scholar
• Horvath B, Hegedus D, Szapary L, Marton Z, Alexy T, Koltai K, Czopf L, Wittmann I, Juricskay I, Toth K, et al. Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases. Exp Clin Cardiol 2004; 9: 31–34
   PubMedGoogle Scholar
• Machado RF. Pulmonary hypertension in sickle cell disease. PVRI Review 2009; 1: 6–12
   Google Scholar
• Onyekwere OC, Campbell A, Teshome M, Onyeagoro S, Sylvan C, Akintilo A, Hutchinson S, Ensing G, Gaskin P, Kato G, et al. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol 2008; 29: 309–312
   PubMed Web of Science ®Google Scholar
• Kato GJ, Hsieh M, Machado R, Taylor J, 6th, Little J, Butman JA, Lehky T, Tisdale J, Gladwin MT. Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol 2006; 81: 503–510
   PubMed Web of Science ®Google Scholar
• Tomer A, Harker LA, Kasey S, Eckman JR. Thrombogenesis in sickle cell disease. J Lab Clin Med 2001; 137: 398–407
   PubMed Web of Science ®Google Scholar
• Rees DC, Williams TN, Gladwin MT. Sickle cell disease. Lancet 2010; 376: 2018–2031
   PubMed Web of Science ®Google Scholar
• Chiang EY, Frenette PS. Sickle cell vaso-occlusion. Hematol Oncol Clin North Am 2005; 19: 771–784
   PubMed Web of Science ®Google Scholar
• Roseff SD. Sickle cell disease: A review. Immunohematology 2009; 25: 67–74
   PubMedGoogle Scholar
• Aessopos A, Farmakis D, Deftereos S, Tsironi M, Polonifi A, Moyssakis I, Diamanti-Kandaraki E, Papalambros E. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia. Ann Hematol 2005; 84: 353–357
   PubMed Web of Science ®Google Scholar
• Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood 2009; 114: 2861–2868
   PubMed Web of Science ®Google Scholar
• Gerotziafas GT, Van Dreden P, Chaari M, Galea V, Khaterchi A, Lionnet F, Stankovic-Stojanovic K, Blanc-Brude O, Woodhams B, Maier-Redelsperger M, et al. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles. Thromb Haemost 2012; 107: 1044–1052
   PubMedGoogle Scholar
• Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ. Platelet activation in patients with sickle cell disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007; 110: 2166–2172
   PubMed Web of Science ®Google Scholar
• Tsironi M, Aessopos A. The heart in sickle cell disease. Acta Cardiol 2005; 60: 589–598
   PubMed Web of Science ®Google Scholar
• Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 2002; 106: 2561–2566
   PubMed Web of Science ®Google Scholar
• Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH. Aortic stiffness: Current understanding and future directions. J Am Coll Cardiol 2011; 47: 1511–1522
   Google Scholar
• Aessopos A, Farmakis D, Tsironi M, Diamanti-Kandarakis E, Matzourani M, Fragodimiri C, Hatziliami A, Karagiorga M. Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis 2007; 191: 427–332
   PubMed Web of Science ®Google Scholar
• Lemogoum D, Van Bortel L, Najem B, Dzudie A, Teutcha C, Madu E, Leeman M, Degaute JP, van de Borne P. Arterial stiffness and wave reflections in patients with sickle cell disease. Hypertension 2004; 44: 924–929
   PubMedGoogle Scholar
• Bellien J, Favre J, Iacob M, Gao J, Thuillez C, Richard V, Joannidès R. Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans. Hypertension 2010; 55: 674–680
   PubMed Web of Science ®Google Scholar
• Elsharawy MA, Moghazy KM, Shawarby MA. Atherosclerosis in sickle cell disease – A review. Int J Angiol 2009; 18: 62–66
   PubMedGoogle Scholar
• Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Jr, Gladwin MT. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005; 294: 81–90
   PubMed Web of Science ®Google Scholar
• Fuentes QE, Fuentes QF, Andrés V, Pello OM, de Mora JF, Palomo GI. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets 2012, [Epub ahead of print]
   Google Scholar